27 May 2013
(MENAFN) Hikma Pharmaceuticals CEO, Mazen Darwazah, announced that the company is allocating between USD400 million and USD600 million to finance acquisitions, reported Arabian Business citing Bloomberg.
The CEO said that Hikma is planning to make acquisitions in Turkey, the Middle East, Africa and the former Soviet Union countries, adding that in 2013, the London-based firm projects to close one small or medium-size deal.
Furthermore, the company, established in Amman in 1978, will spend USD100 million to make acquisitions and launch new business in sub-Saharan Africa.
It is worth noting that Hikma, which has production facilities in several countries including Jordan, Saudi Arabia, Algeria, Egypt and Morocco, agreed to pay USD22.2 million to buy Egyptian Company for Pharmaceuticals & Chemical Industries.
20 Jul 2025
CBB approves the transfer of the retail banking operations of HSBC Bank Middle East, Bahrain Branch to BBK
02 Jul 2025
BBK launches the largest-ever Al Hayrat Prizes, offering BD 5 million to over 2,000 winners
12 May 2025
Alsharifi: “Proud of our strategic partnership with the Royal Humanitarian Foundation”
04 May 2025
BBK offers exclusive Mortgage Loans for luxury villas and apartments on Reef Island
30 Apr 2025
BBK discloses its financial results for the first quarter ended 31st March 2025
25 Mar 2025
BBK’s General Assembly Approves 35% Cash Dividend Distribution to Shareholders
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more